[Post-marketing surveillance on treatment of 5,665 patients with atopic dermatitis using the calcineurin inhibitor pimecrolimus: positive effects on major symptoms of atopic dermatitis and on quality of life].
about
Topical pimecrolimus for skin disease other than atopic dermatitis.Clinical experience and psychometric properties of the Children's Dermatology Life Quality Index (CDLQI), 1995-2012.Treatment of atopic dermatitis with pimecrolimus - impact on quality of life.Quality of life impact of childhood skin conditions measured using the Children's Dermatology Life Quality Index (CDLQI): a meta-analysis.Safety and efficacy of pimecrolimus cream 1% in the daily practice: results of a patient self-observation study in patients with atopic dermatitis.
P2860
[Post-marketing surveillance on treatment of 5,665 patients with atopic dermatitis using the calcineurin inhibitor pimecrolimus: positive effects on major symptoms of atopic dermatitis and on quality of life].
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
[Post-marketing surveillance o ...... titis and on quality of life].
@en
[Post-marketing surveillance o ...... titis and on quality of life].
@nl
type
label
[Post-marketing surveillance o ...... titis and on quality of life].
@en
[Post-marketing surveillance o ...... titis and on quality of life].
@nl
prefLabel
[Post-marketing surveillance o ...... titis and on quality of life].
@en
[Post-marketing surveillance o ...... titis and on quality of life].
@nl
P2093
P2860
P1433
P1476
[Post-marketing surveillance o ...... titis and on quality of life].
@en
P2093
Dirk Schneider
Helena Löffler
Raphael Bextermöller
P2860
P304
P356
10.1111/J.1610-0387.2006.05932.X
P407
P577
2006-04-01T00:00:00Z